Skip to main content
OpenTrials

Clinical trial condition

Neoplasm Metastasis

Explore clinical trials studying Neoplasm Metastasis. Study availability and eligibility vary by location and protocol.

2,438 public trials 498 recruiting studies
Refine in advanced search Browse all conditions

Neoplasm Metastasis trial results

Completed

Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer

NCT02595866

Conditions
AIDS-Related Non-Hodgkin Lymphoma, Adenocarcinoma, Blood-Borne Infections, +76 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Zuckerberg San Francisco General Hospital San Francisco, California, United States
  • UCSF Medical Center-Parnassus San Francisco, California, United States
  • Yale University New Haven, Connecticut, United States
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GIST

NCT01294202

Conditions
Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +11 more
Locations
  • Arizona Cancer Center at UMC North Tucson, Arizona, United States
  • Robert H. Lurie Cancer Center of Northwestern University Chicago, Illinois, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Completed

Trilaciclib, a CDK 4/6 Inhibitor, in Patients Receiving Gemcitabine and Carboplatin for Metastatic Triple-Negative Breast Cancer (TNBC)

NCT04799249

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +10 more
Locations
  • Banner M.D. Anderson Cancer Center Gilbert, Arizona, United States
  • Washington Cancer Institute at MedStar Washington Hospital Center - Oncology Research Washington D.C., District of Columbia, United States
  • Florida Cancer Specialists - North (SCRI) St. Petersburg, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
View all 71 locations
View Trial Details
Completed

Study of S 95005 in Combination With Oxaliplatin in Metastatic Colorectal Cancer

NCT02848443

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Allgemeines Krankenhaus - Universitätskliniken Klinische Abteilung für Onkologie Vienna, Austria
  • CHU de la Timone Hépato-Gastro-Entérologie - Oncology Digestive Marseille, France
  • Hôpital Saint-Antoine Service d'Oncologie Médicale Paris, France
  • La Pitié Salpêtrière Centre Investigation clinique Paris Est Paris, France
View all 24 locations
View Trial Details
Completed

Study of Efficacy and Safety of S 95005 (TAS-102) in Patients With Metastatic Colorectal Cancer Who Failed Standard Chemotherapies

NCT03274882

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Russian Cancer Research Center n.a. NN Blokhin (RCRC), Clinical Pharmacology and Chemotherapy department Moscow, Russia
  • Saint Petersburg Clinical Scientific-Practical Center of Special Medical Care (Oncology Center) Saint Petersburg, Russia
View Trial Details
Completed

A Study of Trifluridine/Tipiracil (Also Known as S 95005 or TAS-102) in Patients With a Pretreated Colorectal Cancer That Has Spread (Metastatic).

NCT03306394

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +13 more
Locations
  • Chris O'Brien Lifehouse Oncology Camperdown, Australia
  • St Vincent's Hospital The Kinghorn Cancer Centre Darlinghurst, Australia
  • St Vincent's Hospital (Melbourne) Cancer Centre Fitzroy, Australia
  • The Canberra Hospital Cancer,Ambulatory & Community Health Service (CACHS) Bldg 19 Garran, Australia
View all 99 locations
View Trial Details
Completed

Evaluation of IGM-7354 in Adults With Relapsed and/or Refractory Cancer

NCT05702424

Conditions
Neoplasm Metastasis, Neoplasms, Neoplastic Processes, +3 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Florida Cancer Specialists & Research Institute Sarasota, Florida, United States
  • Carolina Biooncology Institute Huntersville, North Carolina, United States
  • Oklahoma University Norman, Oklahoma, United States
View Trial Details

Related conditions